vs
Side-by-side financial comparison of Fidelity National Financial, Inc. (FNF) and Bio-Techne (TECH). Click either name above to swap in a different company.
Fidelity National Financial, Inc. is the larger business by last-quarter revenue ($544.0M vs $295.9M, roughly 1.8× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs -21.5%, a 34.4% gap on every dollar of revenue. On growth, Fidelity National Financial, Inc. posted the faster year-over-year revenue change (10.3% vs -6.4%). Over the past eight quarters, Fidelity National Financial, Inc.'s revenue compounded faster (13.7% CAGR vs 4.2%).
Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
FNF vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $544.0M | $295.9M |
| Net Profit | $-117.0M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 82.9% | 18.4% |
| Net Margin | -21.5% | 12.8% |
| Revenue YoY | 10.3% | -6.4% |
| Net Profit YoY | -126.0% | 68.3% |
| EPS (diluted) | $-0.44 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $544.0M | $295.9M | ||
| Q3 25 | $553.0M | — | ||
| Q2 25 | $547.0M | $317.0M | ||
| Q1 25 | $455.0M | $316.2M | ||
| Q4 24 | $493.0M | $297.0M | ||
| Q3 24 | $506.0M | $289.5M | ||
| Q2 24 | $504.0M | $306.1M | ||
| Q1 24 | $421.0M | $303.4M |
| Q4 25 | $-117.0M | $38.0M | ||
| Q3 25 | $358.0M | — | ||
| Q2 25 | $278.0M | $-17.7M | ||
| Q1 25 | $83.0M | $22.6M | ||
| Q4 24 | $450.0M | $34.9M | ||
| Q3 24 | $266.0M | $33.6M | ||
| Q2 24 | $306.0M | $40.6M | ||
| Q1 24 | $248.0M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 82.9% | 18.4% | ||
| Q3 25 | 81.9% | — | ||
| Q2 25 | 69.8% | -7.5% | ||
| Q1 25 | 24.4% | 12.2% | ||
| Q4 24 | — | 16.0% | ||
| Q3 24 | 61.9% | 13.8% | ||
| Q2 24 | 90.9% | 15.0% | ||
| Q1 24 | 78.6% | 22.1% |
| Q4 25 | -21.5% | 12.8% | ||
| Q3 25 | 64.7% | — | ||
| Q2 25 | 50.8% | -5.6% | ||
| Q1 25 | 18.2% | 7.1% | ||
| Q4 24 | 91.3% | 11.7% | ||
| Q3 24 | 52.6% | 11.6% | ||
| Q2 24 | 60.7% | 13.3% | ||
| Q1 24 | 58.9% | 16.2% |
| Q4 25 | $-0.44 | $0.24 | ||
| Q3 25 | $1.33 | — | ||
| Q2 25 | $1.02 | $-0.11 | ||
| Q1 25 | $0.30 | $0.14 | ||
| Q4 24 | $1.65 | $0.22 | ||
| Q3 24 | $0.97 | $0.21 | ||
| Q2 24 | $1.12 | $0.26 | ||
| Q1 24 | $0.91 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.6B | $172.9M |
| Total DebtLower is stronger | $4.4B | $260.0M |
| Stockholders' EquityBook value | $7.4B | $2.0B |
| Total Assets | $109.0B | $2.5B |
| Debt / EquityLower = less leverage | 0.59× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.6B | $172.9M | ||
| Q3 25 | $3.5B | — | ||
| Q2 25 | $3.3B | $162.2M | ||
| Q1 25 | $4.5B | $140.7M | ||
| Q4 24 | $3.5B | $177.5M | ||
| Q3 24 | $5.0B | $187.5M | ||
| Q2 24 | $4.9B | $152.9M | ||
| Q1 24 | $3.5B | $145.3M |
| Q4 25 | $4.4B | $260.0M | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.4B | $346.0M | ||
| Q1 25 | $4.4B | $330.0M | ||
| Q4 24 | $4.3B | $300.0M | ||
| Q3 24 | $4.2B | $300.0M | ||
| Q2 24 | $4.2B | $319.0M | ||
| Q1 24 | $3.9B | $389.0M |
| Q4 25 | $7.4B | $2.0B | ||
| Q3 25 | $8.4B | — | ||
| Q2 25 | $7.9B | $1.9B | ||
| Q1 25 | $7.9B | $2.0B | ||
| Q4 24 | $7.8B | $2.1B | ||
| Q3 24 | $8.1B | $2.1B | ||
| Q2 24 | $7.3B | $2.1B | ||
| Q1 24 | $7.1B | $2.0B |
| Q4 25 | $109.0B | $2.5B | ||
| Q3 25 | $106.6B | — | ||
| Q2 25 | $102.3B | $2.6B | ||
| Q1 25 | $98.2B | $2.6B | ||
| Q4 24 | $95.4B | $2.7B | ||
| Q3 24 | $94.7B | $2.7B | ||
| Q2 24 | $88.8B | $2.7B | ||
| Q1 24 | $84.5B | $2.7B |
| Q4 25 | 0.59× | 0.13× | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.56× | 0.18× | ||
| Q1 25 | 0.56× | 0.16× | ||
| Q4 24 | 0.56× | 0.14× | ||
| Q3 24 | 0.52× | 0.14× | ||
| Q2 24 | 0.58× | 0.15× | ||
| Q1 24 | 0.55× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.5B | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.9B | $98.2M | ||
| Q1 25 | $1.1B | $41.1M | ||
| Q4 24 | $1.5B | $84.3M | ||
| Q3 24 | $2.4B | $63.9M | ||
| Q2 24 | $1.4B | $75.5M | ||
| Q1 24 | $1.6B | $81.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.3M | ||
| Q1 25 | — | $31.0M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | — | $54.7M | ||
| Q2 24 | — | $57.5M | ||
| Q1 24 | — | $64.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 29.4% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 18.9% | ||
| Q2 24 | — | 18.8% | ||
| Q1 24 | — | 21.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | 5.9% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | — | — | ||
| Q3 25 | 3.66× | — | ||
| Q2 25 | 6.82× | — | ||
| Q1 25 | 13.43× | 1.82× | ||
| Q4 24 | 3.32× | 2.42× | ||
| Q3 24 | 8.89× | 1.90× | ||
| Q2 24 | 4.45× | 1.86× | ||
| Q1 24 | 6.42× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FNF
| Escrow Fees | $241.0M | 44% |
| Other Title Related Fees And Income | $182.0M | 33% |
| Service Link Excluding Title Premiums Escrow Fees And Subservicing Fees | $87.0M | 16% |
| Insurance Contracts Home Warranty | $31.0M | 6% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
